Form 8-K - Current report:
SEC Accession No. 0001140361-25-017011
Filing Date
2025-05-02
Accepted
2025-05-02 08:00:19
Documents
19
Period of Report
2025-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20048241_8k.htm   iXBRL 8-K 53812
2 EXHIBIT 4.1 ef20048241_ex4-1.htm EX-4.1 172431
3 EXHIBIT 4.2 ef20048241_ex4-2.htm EX-4.2 87684
4 EXHIBIT 10.1 ef20048241_ex10-1.htm EX-10.1 210177
5 EXHIBIT 10.2 ef20048241_ex10-2.htm EX-10.2 136690
6 EXHIBIT 10.3 ef20048241_ex10-3.htm EX-10.3 125687
7 EXHIBIT 10.4 ef20048241_ex10-4.htm EX-10.4 58171
  Complete submission text file 0001140361-25-017011.txt   1196569

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20250430.xsd EX-101.SCH 3988
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20250430_lab.xml EX-101.LAB 21966
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20250430_pre.xml EX-101.PRE 16048
22 EXTRACTED XBRL INSTANCE DOCUMENT ef20048241_8k_htm.xml XML 4076
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 25905536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)